El viernes 27, Hadrián Álvarez Fernández (Grupo Nucleósidos) presentará su trabajo "Allosteric Inhibition of Neutral Sphingomyelinase 2 (nSMase2) by DPTIP: From Antiflaviviral Activity to Deciphering Its Binding Site through In Silico Studies and Experimental Validation"

Coloquio @11defebreroES organizado por la Comisión de Igualdad Intercentros
@CSIC + @UAM_Madrid: "Carolyn Bertozzi: Cuando la química hace click"

🗣 Fernando Herranz (@IQM_CSIC @NanoMedMol @Nanomed_CSIC)
🗓️9 de febrero 🕧 12:30 hrs
📍 Facultad de @CienciasUAM

#ConexionesCSIC

Publications

  1. Alkorta, I, Plane, JMC, Elguero, J, Dávalos, JZ, Acuña, AU, Saiz-Lopez, A et al.. Reply to the 'Comment on "Theoretical study of the NO3 radical reaction with CH2ClBr, CH2ICl, CH2BrI, CHCl2Br, and CHClBr2"' by C. J. Nielsen and Y. Tang, Phys. Chem. Chem. Phys., 2022, 24, DOI: 10.1039/D2CP03013F. Phys Chem Chem Phys. 2023;25 (5):4357-4358. doi: 10.1039/d2cp04659h. PubMed PMID:36656745 .
  2. Gómez-Cañas, M, Morales, P, Satta, V, Rodríguez-Cueto, C, García, C, Sagredo, O et al.. Editorial: Cannabinoids as potential treatment for neurological diseases. Front Neurosci. 2022;16 :1108101. doi: 10.3389/fnins.2022.1108101. PubMed PMID:36605545 PubMed Central PMC9808380.
  3. Algar-Lizana, S, Bonache, MÁ, González-Muñiz, R. SARS-CoV-2 main protease inhibitors: What is moving in the field of peptides and peptidomimetics?. J Pept Sci. 2022; :e3467. doi: 10.1002/psc.3467. PubMed PMID:36479966 PubMed Central PMC9877768.
Search PubMed
PHP Code Snippets Powered By : XYZScripts.com